SLC71A2
gene geneOn this page
Also known as FLJ14753
Summary
SLC71A2 (solute carrier family 71 member 2, HGNC:23376) is a protein-coding gene on chromosome 9q22.32, encoding Solute carrier family 71 member 2 (Q5SR56). Probable membrane-bound transporter.
Predicted to enable transmembrane transporter activity. Predicted to be involved in transmembrane transport. Predicted to be located in membrane.
Source: NCBI Gene 84641 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 24 total
- MANE Select transcript:
NM_032558
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23376 |
| Approved symbol | SLC71A2 |
| Name | solute carrier family 71 member 2 |
| Location | 9q22.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ14753 |
| Ensembl gene | ENSG00000148110 |
| Ensembl biotype | protein_coding |
| OMIM | 620348 |
| Entrez | 84641 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 14 protein_coding, 1 retained_intron
ENST00000375344, ENST00000673506, ENST00000885150, ENST00000885151, ENST00000885152, ENST00000885153, ENST00000885154, ENST00000885155, ENST00000885156, ENST00000885157, ENST00000885158, ENST00000934655, ENST00000934656, ENST00000934657, ENST00000960207
RefSeq mRNA: 1 — MANE Select: NM_032558
NM_032558
CCDS: CCDS6710
Canonical transcript exons
ENST00000375344 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000983145 | 94446823 | 94446936 |
| ENSE00000983147 | 94453958 | 94454070 |
| ENSE00001405625 | 94440985 | 94441099 |
| ENSE00001466765 | 94444964 | 94445182 |
| ENSE00001703347 | 94415158 | 94415253 |
| ENSE00001759465 | 94456240 | 94456337 |
| ENSE00001776723 | 94429189 | 94429251 |
| ENSE00001793304 | 94438401 | 94438528 |
| ENSE00001947305 | 94459161 | 94461042 |
| ENSE00002704858 | 94374569 | 94374927 |
| ENSE00003622559 | 94458322 | 94458464 |
| ENSE00003718447 | 94451456 | 94451527 |
Expression profiles
Bgee: expression breadth ubiquitous, 256 present calls, max score 98.40.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 28.1346 / max 371.8702, expressed in 1823 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 97456 | 20.0866 | 1819 |
| 97455 | 7.2584 | 1776 |
| 97454 | 0.7896 | 542 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oviduct epithelium | UBERON:0004804 | 98.40 | gold quality |
| upper arm skin | UBERON:0004263 | 97.23 | gold quality |
| gingival epithelium | UBERON:0001949 | 96.96 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 96.59 | gold quality |
| secondary oocyte | CL:0000655 | 96.20 | gold quality |
| gingiva | UBERON:0001828 | 96.16 | gold quality |
| ileal mucosa | UBERON:0000331 | 95.99 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 95.70 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 95.25 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 95.20 | gold quality |
| monocyte | CL:0000576 | 94.91 | gold quality |
| leukocyte | CL:0000738 | 94.72 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 93.74 | gold quality |
| tibia | UBERON:0000979 | 93.52 | gold quality |
| esophagus mucosa | UBERON:0002469 | 93.52 | gold quality |
| upper leg skin | UBERON:0004262 | 93.46 | gold quality |
| oocyte | CL:0000023 | 93.22 | gold quality |
| oral cavity | UBERON:0000167 | 93.16 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 92.92 | gold quality |
| fallopian tube | UBERON:0003889 | 92.88 | gold quality |
| endometrium | UBERON:0001295 | 92.77 | gold quality |
| skin of abdomen | UBERON:0001416 | 92.52 | gold quality |
| skin of hip | UBERON:0001554 | 92.44 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 92.42 | gold quality |
| zone of skin | UBERON:0000014 | 92.35 | gold quality |
| bronchial epithelial cell | CL:0002328 | 92.28 | gold quality |
| right lung | UBERON:0002167 | 92.21 | gold quality |
| skin of leg | UBERON:0001511 | 92.20 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 92.04 | gold quality |
| vagina | UBERON:0000996 | 92.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.96 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
124 targeting SLC71A2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-103A-3P | 99.98 | 69.14 | 1595 |
| HSA-MIR-107 | 99.98 | 69.14 | 1595 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
Literature-anchored findings (GeneRIF, showing 1)
- We identified interaction between CRC risk and alcohol consumption and variants in the 9q22.32/HIATL1 region. Compared to non-/occasional drinking light to moderate alcohol consumption was associated with a lower risk of colorectal cancer among individuals with rs9409565 CT genotype and TT genotypes (PMID:27723779)
Cross-species orthologs
18 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ENSDARG00000010023 | |
| danio_rerio | mfsd14bb | ENSDARG00000030129 |
| mus_musculus | Mfsd14b | ENSMUSG00000038212 |
| rattus_norvegicus | Mfsd14b | ENSRNOG00000018227 |
| drosophila_melanogaster | CG11537 | FBGN0035400 |
| drosophila_melanogaster | CG18281 | FBGN0037003 |
| drosophila_melanogaster | CG17637 | FBGN0037004 |
| drosophila_melanogaster | CG5078 | FBGN0037005 |
| caenorhabditis_elegans | WBGENE00010182 | |
| caenorhabditis_elegans | WBGENE00010282 | |
| caenorhabditis_elegans | WBGENE00012222 | |
| caenorhabditis_elegans | WBGENE00016093 | |
| caenorhabditis_elegans | WBGENE00016094 | |
| caenorhabditis_elegans | WBGENE00016095 | |
| caenorhabditis_elegans | WBGENE00017861 | |
| caenorhabditis_elegans | WBGENE00020798 | |
| caenorhabditis_elegans | WBGENE00021814 | |
| caenorhabditis_elegans | WBGENE00021870 |
Paralogs (6): MFSD10 (ENSG00000109736), MFSD1 (ENSG00000118855), MFSD9 (ENSG00000135953), MFSD14A (ENSG00000156875), MFSD8 (ENSG00000164073), MFSD5 (ENSG00000182544)
Protein
Protein identifiers
Solute carrier family 71 member 2 — Q5SR56 (reviewed: Q5SR56)
Alternative names: Hippocampus abundant transcript-like protein 1, Major facilitator superfamily domain-containing 14B
All UniProt accessions (1): Q5SR56
UniProt curated annotations — full annotation on UniProt →
Function. Probable membrane-bound transporter. May play a role in neuronal nutrient sensing and energy homeostasis.
Subcellular location. Endoplasmic reticulum membrane.
Similarity. Belongs to the SLC71A transporter family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5SR56-1 | 1 | yes |
| Q5SR56-2 | 2 |
RefSeq proteins (1): NP_115947* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001958 | Tet-R_TetA/multi-R_MdtG-like | Family |
| IPR005829 | Sugar_transporter_CS | Conserved_site |
| IPR011701 | MFS | Family |
| IPR020846 | MFS_dom | Domain |
| IPR036259 | MFS_trans_sf | Homologous_superfamily |
Pfam: PF07690
UniProt features (35 total): topological domain 13, transmembrane region 12, splice variant 3, region of interest 2, chain 1, compositionally biased region 1, glycosylation site 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5SR56-F1 | 77.00 | 0.52 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 463
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 130 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_UP, GSE45365_NK_CELL_VS_BCELL_UP, TGGTGCT_MIR29A_MIR29B_MIR29C, IVANOVA_HEMATOPOIESIS_MATURE_CELL, ACATATC_MIR190, DOUGLAS_BMI1_TARGETS_DN, chr9q22, FOXJ2_02, GATA4_Q3, ACEVEDO_LIVER_CANCER_UP, TGCCTTA_MIR124A, MILI_PSEUDOPODIA_CHEMOTAXIS_DN, GOBP_TRANSMEMBRANE_TRANSPORT, SENESE_HDAC3_TARGETS_DN, MORI_MATURE_B_LYMPHOCYTE_UP
GO Biological Process (1): transmembrane transport (GO:0055085)
GO Molecular Function (2): transmembrane transporter activity (GO:0022857), protein binding (GO:0005515)
GO Cellular Component (2): endoplasmic reticulum membrane (GO:0005789), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 1 |
| cellular process | 1 |
| transporter activity | 1 |
| transmembrane transport | 1 |
| binding | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
496 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC71A2 | SLC61A1 | Q6N075 | 575 |
| SLC71A2 | MFSD6 | Q6ZSS7 | 516 |
| SLC71A2 | MFSD6L | Q8IWD5 | 482 |
| SLC71A2 | SLC33A2 | Q96ES6 | 480 |
| SLC71A2 | MFSD12 | Q6NUT3 | 478 |
| SLC71A2 | MFSD11 | O43934 | 474 |
| SLC71A2 | LRRC71 | Q8N4P6 | 463 |
| SLC71A2 | SLC37A3 | Q8NCC5 | 458 |
| SLC71A2 | SLC68A1 | Q14CX5 | 445 |
| SLC71A2 | TATDN3 | Q17R31 | 418 |
| SLC71A2 | SPNS3 | Q6ZMD2 | 413 |
| SLC71A2 | UNC93A | Q86WB7 | 406 |
| SLC71A2 | SLC67A2 | Q8NBP5 | 387 |
| SLC71A2 | SVOPL | Q8N434 | 380 |
| SLC71A2 | MFSD1 | Q9H3U5 | 373 |
IntAct
229 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LPCAT2 | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| BNIP3 | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| LEPROTL1 | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| PEX16 | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 | |
| GRM2 | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ERG28 | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM19 | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| MS4A1 | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCL4L1 | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TUSC5 | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFSD14B | TPRG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFSD14B | FUNDC2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFSD14B | YIPF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFSD14B | USE1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| COMT | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ADIPOQ | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPGB | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSNARE1 | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFSD14B | CSGALNACT2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOSR2 | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFSD14B | TIMMDC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFSD14B | SLC39A9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLDN4 | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (105): HIATL1 (Affinity Capture-RNA), HIATL1 (Affinity Capture-RNA), HIATL1 (Two-hybrid), HIATL1 (Two-hybrid), HIATL1 (Two-hybrid), HIATL1 (Two-hybrid), HIATL1 (Two-hybrid), HIATL1 (Two-hybrid), HIATL1 (Two-hybrid), HIATL1 (Two-hybrid), HIATL1 (Two-hybrid), HIATL1 (Two-hybrid), HIATL1 (Two-hybrid), HIATL1 (Two-hybrid), HIATL1 (Two-hybrid)
ESM2 similar proteins: A1Z7R6, A2AWR3, A4IF94, A4IHK6, A5D7V7, B2RXV4, B2RYH9, O75387, P34711, P42557, P58355, P70187, Q09428, Q0P5V9, Q0VCM6, Q4LE88, Q5BK75, Q5BKX6, Q5F4B8, Q5RBM3, Q5RF58, Q5SR56, Q7Z3Q1, Q866G7, Q8BIV7, Q8BSM7, Q8C0T7, Q8CA03, Q8CGA3, Q8CIA9, Q8HYW2, Q8K0H7, Q8K4S3, Q8N370, Q8NBP5, Q8R3L5, Q96MC6, Q99624, Q99N02, Q9BY10
Diamond homologs: A4IF94, B2RYH9, P70187, Q0P5M9, Q5SR56, Q5VZR4, Q8CIA9, Q96MC6, K5B8L6, M2YI75, P02980, Q14728, Q8TFD3, Q9D2V8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2763 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:94395632:G:GT | donor_gain | 1.0000 |
| 9:94415153:TTTA:T | acceptor_loss | 1.0000 |
| 9:94415156:A:AG | acceptor_gain | 1.0000 |
| 9:94415157:G:GT | acceptor_gain | 1.0000 |
| 9:94415157:GC:G | acceptor_gain | 1.0000 |
| 9:94415157:GCT:G | acceptor_gain | 1.0000 |
| 9:94415157:GCTA:G | acceptor_gain | 1.0000 |
| 9:94415157:GCTAC:G | acceptor_gain | 1.0000 |
| 9:94415249:TGACT:T | donor_gain | 1.0000 |
| 9:94415250:GACT:G | donor_gain | 1.0000 |
| 9:94415250:GACTG:G | donor_gain | 1.0000 |
| 9:94415251:ACT:A | donor_gain | 1.0000 |
| 9:94415252:CT:C | donor_gain | 1.0000 |
| 9:94415253:TG:T | donor_loss | 1.0000 |
| 9:94415254:G:GA | donor_loss | 1.0000 |
| 9:94415254:G:GG | donor_gain | 1.0000 |
| 9:94415255:TA:T | donor_loss | 1.0000 |
| 9:94415256:AA:A | donor_loss | 1.0000 |
| 9:94429248:AAAG:A | donor_loss | 1.0000 |
| 9:94429252:G:A | donor_loss | 1.0000 |
| 9:94429253:T:G | donor_loss | 1.0000 |
| 9:94438395:CTCCA:C | acceptor_loss | 1.0000 |
| 9:94438396:TCCA:T | acceptor_loss | 1.0000 |
| 9:94438397:CCA:C | acceptor_loss | 1.0000 |
| 9:94438398:CA:C | acceptor_loss | 1.0000 |
| 9:94438399:A:AG | acceptor_gain | 1.0000 |
| 9:94438399:AG:A | acceptor_gain | 1.0000 |
| 9:94438399:AGGGC:A | acceptor_loss | 1.0000 |
| 9:94438400:G:A | acceptor_loss | 1.0000 |
| 9:94438400:G:GG | acceptor_gain | 1.0000 |
AlphaMissense
3289 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:94438459:G:T | R109M | 1.000 |
| 9:94429243:G:C | G87R | 0.999 |
| 9:94438435:G:A | G101D | 0.999 |
| 9:94438444:C:T | S104F | 0.999 |
| 9:94438459:G:C | R109T | 0.999 |
| 9:94438460:G:C | R109S | 0.999 |
| 9:94438460:G:T | R109S | 0.999 |
| 9:94441055:G:C | A156P | 0.999 |
| 9:94444971:C:A | A173D | 0.999 |
| 9:94444985:A:C | S178R | 0.999 |
| 9:94444987:T:A | S178R | 0.999 |
| 9:94444987:T:G | S178R | 0.999 |
| 9:94444997:A:C | S182R | 0.999 |
| 9:94444999:C:A | S182R | 0.999 |
| 9:94444999:C:G | S182R | 0.999 |
| 9:94415215:T:C | F56L | 0.998 |
| 9:94415217:C:A | F56L | 0.998 |
| 9:94415217:C:G | F56L | 0.998 |
| 9:94415227:G:C | G60R | 0.998 |
| 9:94415231:T:C | L61P | 0.998 |
| 9:94438401:G:C | G90R | 0.998 |
| 9:94438434:G:C | G101R | 0.998 |
| 9:94438443:T:C | S104P | 0.998 |
| 9:94438444:C:A | S104Y | 0.998 |
| 9:94438471:T:C | L113P | 0.998 |
| 9:94441047:C:A | A153D | 0.998 |
| 9:94441058:G:C | D157H | 0.998 |
| 9:94441059:A:T | D157V | 0.998 |
| 9:94444970:G:C | A173P | 0.998 |
| 9:94444976:T:C | F175L | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000013177 (9:94402222 C>G), RS1000049978 (9:94459854 C>A), RS1000080909 (9:94408586 G>C), RS1000102293 (9:94449002 A>C), RS1000119178 (9:94377149 T>C), RS1000134533 (9:94408291 G>A), RS1000142906 (9:94460277 G>A,C), RS1000160715 (9:94454727 ATGAC>A), RS1000184461 (9:94457280 T>C), RS1000236029 (9:94374341 A>T), RS1000266628 (9:94454493 G>A), RS1000267274 (9:94374225 C>T), RS1000293220 (9:94420194 C>A), RS1000334636 (9:94460426 A>AATC), RS1000386229 (9:94419932 T>A)
Disease associations
OMIM: gene MIM:620348 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003873_1 | Colorectal cancer (alcohol consumption interaction) | 2.000000e-08 |
| GCST003873_2 | Colorectal cancer (alcohol consumption interaction) | 1.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Arsenic | decreases expression, increases abundance, affects methylation | 2 |
| Valproic Acid | increases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | decreases expression, increases abundance | 1 |
| beryllium sulfate | decreases expression | 1 |
| manganese chloride | increases abundance, increases expression | 1 |
| abrine | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Diuron | decreases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Nickel | decreases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Vitamin E | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4GH | HCT116-MFSD14B-KO-c2 | Cancer cell line | Male |
| CVCL_D4GI | HCT116-MFSD14B-KO-c3 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.